Cannabinoids potentiate emotional learning plasticity in neurons of the medial prefrontal cortex through basolateral amygdala inputs
Open accessAbstract
Cannabinoids represent one of the most commonly used hallucinogenic drug classes. In addition, cannabis use is a primary risk factor for schizophrenia in susceptible individuals and can potently modulate the emotional salience of sensory stimuli. We report that systemic activation or blockade of cannabinoid CB1 receptors modulates emotional associative learning and memory formation in a subpopulation of neurons in the mammalian medial prefrontal cortex (mPFC) that receives functional input from the basolateral amygdala (BLA). Using in vivo single-unit recordings in rats, we found that a CB1 receptor agonist potentiated the response of medial prefrontal cortical neurons to olfactory cues paired previously with a footshock, whereas this associative responding was prevented by a CB1 receptor antagonist. In an olfactory fear-conditioning procedure, CB1 agonist microinfusions into the mPFC enabled behavioral responses to olfactory cues paired with normally subthreshold footshock, whereas the antagonist completely blocked emotional learning. These results are the first demonstration that cannabinoid signaling in the mPFC can modulate the magnitude of neuronal emotional learning plasticity and memory formation through functional inputs from the BLA.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The effects of ECBs on fear are not restricted to the BLA but involve a pathway between the BLA and mPFC.
“These effects on fear are not restricted to the BLA but involve a pathway between the BLA and mPFC.”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [83]
Responses to fear cues in mPFC neurons receiving inputs from BLA were potentiated by the CB1R agonist WIN55212-2, and CB1R blockade/inverse agonism with AM251 in these regions disrupts fear learning and learning-related long-term potentiation.
“Responses to fear cues in mPFC neurons receiving inputs from BLA were potentiated by the CB1R agonist WIN55212-2, and CB1R blockade/inverse agonism (with AM251) in these regions disrupts fear learning and learning-related synaptic plasticity (long-term potentiation) [83–85].”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [83]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 52 · Cited by 189
- Authors
- Laviolette, S. R., & Grace, A. A.
- Affiliations
- University of Pittsburgh (US)
- Venue
- Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2006-06-14
- Volume
- 26
- Issue
- 24
- Pages
- 6458-6468
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6674051
- OpenAlex
- W1969305409
- Cited by
- 189
- References
- 52
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 4 · 2021: 7 · 2020: 8 · 2019: 5 · 2018: 10 · 2017: 9 · 2016: 8 · 2015: 14 · 2014: 16 · 2013: 12 · 2012: 14
- FWCI
- 8.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- U.S. Public Health Service (DA15408)
- Canadian Institutes of Health Research
- National Institute of Mental Health (MH 45156, P50MH045156)
- National Institute on Drug Abuse (DA 15408)
- Topics
- Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- cannabinoids, CB1 receptor, medial prefrontal cortex, basolateral amygdala, fear conditioning, neuroplasticity, memory formation, single-unit recording
- MeSH terms
- Action Potentials, Amygdala, Animals, Association Learning, Behavior, Animal, Calcium Channel Blockers, Cannabinoids, Dose-Response Relationship, Drug, Drug Interactions, Electroshock, Fear, Male, Morpholines, Naphthalenes, Neuronal Plasticity, Neurons, Piperidines, Pyrazoles, Rats, Sprague-Dawley, Prefrontal Cortex, Benzoxazines, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review